Prader Willi Syndrome Therapeutic Development Review 2015

RnRMarketResearch.com adds “Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2015” to its store. This report provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS), complete with comparative analysis at various stages.

Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2015′, provides an overview of the Prader-Willi Syndrome (PWS)’s therapeutic pipeline.

Prader-Willi syndrome is a complex genetic condition that affects many parts of the body and is Present at birth. It may be caused by a problem in a portion of the brain called the hypothalamus. An important early symptom of Prader-Willi Syndrome is an infant’s inability to suck, which affects the ability to feed. Nearly all infants with PWS need help with feeding. Signs may include Poor muscle tone, distinct facial features, and failure to thrive. Children will experience puberty later than usual and may not go through full development into an adult. Other features of Prader-Willi syndrome appear during early childhood and remain throughout life, requiring careful management or treatment.

This report provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Prader-Willi Syndrome (PWS) and special features on late-stage and discontinued projects.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete Report is Available http://www.rnrmarketresearch.com/prader-willi-syndrome-pws-pipeline-review-h1-2015-market-report.html .

Scope:

• The report provides a snapshot of the global therapeutic landscape of Prader-Willi Syndrome (PWS).
• The report reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.
• The report reviews key players involved in the therapeutics development for Prader-Willi Syndrome (PWS) and enlists all their major and minor projects.
• The report summarizes all the dormant and discontinued pipeline projects.
• A review of the Prader-Willi Syndrome (PWS) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=269600 . (This is a premium report priced at US$2000 for a single user License.)

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.